Boston Scientific’s fair value estimate has been adjusted from US$104.24 to US$102.00, a modest trim that lines up with the recent wave of price target resets across the Street. Analysts are not ...
Original Image Link
Source:finance.yahoo.com
Original Image Link
Source:finance.yahoo.com
Posted: 2026-03-26 04:18:00

















